| Literature DB >> 29410796 |
Chacha M Issarow1, Nicola Mulder1, Robin Wood2.
Abstract
Tuberculosis (TB) transmission results from the interaction between infective sources and susceptible individuals within enabling socio-environmental conditions. As TB is an airborne pathogen, the transmission probability is determined by the volume of air inhaled from an infected source and the concentration of Mycobacterium tuberculosis containing respirable particles (doses) per volume of air. In this study, we model the contributions of infectious dose production, prevalence of infectious cases and daily rebreathed air volume (RAV) for defining the boundary conditions necessary to sustain endemic TB transmission at the population level. Results suggest that in areas with high RAV (range 300-1000 l d-1), such as prisons, TB transmission is contributed by both super-spreaders (exhaling ≥10 infectious doses hr-1) and lower infectivity individuals (exhaling less than 10 infectious doses hr-1). In settings with a low quantity of RAV (less than 100 l d-1), TB transmission occurs only from super-spreaders. Point-source epidemics occur in low rebreathed environments when super-spreaders infect a number of susceptibles but subsequent transmission is limited by the mean infectivity of secondary cases. By contrast, endemic TB occurs in poor socio-environmental conditions where mean infectivity cases are able to maintain a sufficiently high effective contact number.Entities:
Keywords: effective contact number; infectiousness period; rebreathed air volume
Year: 2018 PMID: 29410796 PMCID: PMC5792873 DOI: 10.1098/rsos.170726
Source DB: PubMed Journal: R Soc Open Sci ISSN: 2054-5703 Impact factor: 2.963
Description of parameters and values used in this study for numerical simulations.
| parameter | description | values | sources |
|---|---|---|---|
| △ | period of infectiousness | 0–14 months (10 months for special cases) | [ |
| TB incidence in South Africa | 834 per 100 000 population | [ | |
| TB prevalence in South Africa | 696 per 100 000 population | [ | |
| ECN | effective contact number per TB cases | 20 and 100 | [ |
| surviving airborne infectious doses | 1–30 doses hr−1 | modelled | |
| alveoli deposition fraction | 0.1 | [ | |
| RAV | rebreathed air volume | 0–1000 l d−1 (100 l d−1 for special cases) | [ |
Figure 1.Proportion of susceptible individuals infected as a function of daily rebreathed air volume. Data shown for source infective dose production between 1 and 30 doses hr−1 using a fixed infectiousness period of 10 months.
Figure 2.Proportion of susceptible individuals infected as a function of infectiousness period. Data shown for source infective dose production between 1 and 30 doses hr−1 using a fixed rebreathed air volume of 100 l d−1.
Figure 3.Quantity of daily rebreathed air volume in scale as a function of infectiousness period for effective contact number of 20 and source infective dose production between 1 and 30 doses hr−1.
Figure 4.Quantity of daily rebreathed air volume in scale as a function of airborne infectious doses for effective contact number of 20 and period of infectiousness ranging between 3 and 14 months.
Figure 5.Quantity of daily rebreathed air volume in scale as a function of infectiousness period for effective contact number of 10 and source infective dose production between 1 and 30 doses hr−1.
Figure 6.Quantity of daily rebreathed air volume in scale as a function of airborne infectious doses for effective contact number of 10 and period of infectiousness ranging between 3 and 14 months.